Document is current
Any future updates will be listed below
-
Authors
Pan, Jinghua
Qiao, Yiting
Chen, Congcong
Zang, Hongjing
Zhang, Xiaojing
Qi, Feng
Chang, Cunjie
Yang, Fan
Sun, Mengqing
Lin, Shengbin
Tang, Quandong
Li, Lina
Wang, Menglan
Wu, Minjie
Liu, Yongzhu https://orcid.org/0000-0002-9205-3841
Lai, Caiyong https://orcid.org/0000-0003-4679-0944
Chen, Jianxiang https://orcid.org/0000-0002-8193-191X
Chen, Guo https://orcid.org/0000-0001-8886-1873
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81803523, 81802338, 82073042)
Natural Science Foundation of Zhejiang Province (LR21H160001)
Natural Science Foundation of Guangdong Province (2019A1515011247)
Guangzhou Municipal Science and Technology Project (202002030451)
- License Information
-
More Information
Article History
Received: 19 February 2021
Revised: 15 September 2021
Accepted: 5 October 2021
First Online: 5 November 2021
Competing interests
: The authors declare no competing interests.
: All animal experiments were approved by the Committee on the Ethics of Animal Experiments of the first affiliated hospital, Zhejiang University, and performed in accordance with the National Institutes of Health guide for the care and use of Laboratory animals. Commercially available human lung cancer tissue microarrays were produced by US Biomax Inc. under the highest ethical standards with the donor being informed completely and with their consent. No human sample ethical approval was required for this study.
